Roivant Sciences Ltd at UBS Global Healthcare Conference Transcript
Good morning, everyone, and thank you so much for coming to the 2022 UBS Global Healthcare Conference. My name is Sylvie Chen, and I'm very happy to be your host for this session.
Our next presenter will be Matthew Gline, Chief Executive Officer from Roivant Sciences. A Q&A session will follow immediately after the presentation. (Operator Instructions) We now turn it over to Matt. Thank you.
Thank you very much, and thank you for having me. I'm thrilled to be here. It's my -- certainly, first New York-based in-person conference in about 2 years. So if I'm a little bit rusty, I apologize. I'm used to doing this from my desk. Sorry, there's various disclaimers here that I think we've mostly run through.
Okay. You're good? Great. There we go. [Alex], that one looks familiar. I have my own disclaimer slide. I'll be making forward-looking statements in the course of today's presentation, and you can consult these disclaimers for more information.
Great. Well, again, thanks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |